This HTML5 document contains 54 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.4049/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q81598429
rdf:type
wikibase:Item
schema:description
գիտական հոդված հրատարակված 2005 թվականի դեկտեմբերի 1-ին scientific article published on 01 December 2005 наукова стаття, опублікована в грудні 2005 wetenschappelijk artikel im Dezember 2005 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2005 artículu científicu espublizáu n'avientu de 2005
p:P577
wds:Q81598429-3838AF0A-9A2B-400C-8A64-551BA9ABBC46
wdt:P577
2005-12-01T00:00:00Z
p:P407
wds:Q81598429-4136820B-9204-48FE-B773-C5A16154FD08
wdt:P407
wd:Q1860
p:P2093
wds:Q81598429-CE5EE82A-97FA-4E3A-930B-4A399978184B wds:Q81598429-AE9FB09A-7992-4BFD-A153-E4DEE75E5C8B wds:Q81598429-C8D0D6E9-BE13-4499-B8C8-B1B57EA0517F wds:Q81598429-5DFD5D0B-8FB0-452B-B2FF-C6E351CA7B99 wds:Q81598429-673586EE-FEE9-4943-9537-AA927D5DCD57 wds:Q81598429-5DFA55C1-55D5-4E66-9311-6BC1AFAE65DA wds:Q81598429-1EE94A43-9676-41A1-938C-215CA241AA0B
wdt:P2093
Michael J Palmowski David C Tscharke Caroline L Smith Valerie Pasquetto Fareed Mirza Adrian L Harris Vincenzo Cerundolo
rdfs:label
Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara
skos:prefLabel
Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara
schema:name
Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara
p:P50
wds:Q81598429-58218E88-2C5F-49E7-B167-EF3EE8490804 wds:Q81598429-D4564093-2BC3-4979-B704-AEE797879B11
wdt:P50
wd:Q62238911 wd:Q28324161
p:P1476
wds:Q81598429-F068D689-DCA8-4749-93E1-6DC37748161E
wdt:P1476
Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara
p:P304
wds:Q81598429-FC0D6B74-61DB-4F78-8262-93EF577B9360
wdt:P304
8431-8437
p:P31
wds:Q81598429-DC8D47A3-274E-411B-BF2F-6144224F4FB5
wdt:P31
wd:Q13442814
p:P698
wds:Q81598429-CC731041-2469-4755-AF4B-6FF7565C90AA
wdtn:P698
n11:16339586
wdt:P698
16339586
p:P1433
wds:Q81598429-A5EE2109-247B-429D-87D2-7A7A4285E2D2
wdt:P1433
wd:Q3521441
p:P433
wds:Q81598429-4A0DD1F7-5A49-4A19-9D8A-2E6322E6E276
p:P478
wds:Q81598429-E6718193-E42C-4832-AA04-B11155E1F46C
wdt:P433
12
wdt:P478
175
p:P356
wds:Q81598429-94F30A89-CCE4-4ED3-AB21-06D1E52DEC09
wdtn:P356
n9:JIMMUNOL.175.12.8431
wdt:P356
10.4049/JIMMUNOL.175.12.8431